http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112255405-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-539 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54313 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-539 |
filingDate | 2020-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112255405-B |
titleOfInvention | Stable serum pepsinogen I determination kit, preparation method and application thereof |
abstract | The invention provides a pepsinogen I (PGI) determination kit, which comprises a reagent R1 and a reagent R2; the reagent R1 contains the following components: piperazine-1, 4-diethylsulfonic acid (PIPES) buffer solution, NaCl, sodium hydroxide, surfactant and preservative. Reagent R2: piperazine-1, 4-diethylsulfonic acid (PIPES) buffer solution, mouse anti-human PGI antibody coated latex particles, suspending agent, stabilizing agent and preservative. The invention also provides a preparation method and application of the kit, the kit can effectively avoid the interference of chylomicron, and different types of protective agents and suspending agents are adopted, so that the kit is a liquid kit with strong stability, high sensitivity, good repeatability and low cost. |
priorityDate | 2020-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.